Medplus Subsidiary's Store Receives Five-Day Drug License Suspension in Karnataka
Medplus Health Services Limited reported that its subsidiary, Optival Health Solutions Private Limited, received a suspension order for a drug license pertaining to a store located in Karnataka.The suspension order was issued by the Assistant Director, Drugs Control Administration, Circle-3 Bangalore, Karnataka, following alleged violations under the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945.
The order, received on April 21, 2026, mandates a five-day suspension of the Drug License for the store situated at 24th Main 4th T Block, Jayanagar, Karnataka.
The following table details the action taken, the violation, and the potential financial impact on the subsidiary's operations.
| Authority Name | Action Taken | Order Date | Violation Details | Financial Impact |
|---|---|---|---|---|
| Assistant Director, Drugs Control Administration, Circle-3 Bangalore, Karnataka | Suspension of Drug License for five days of store situated at 24th Main 4th T Block Jayanagar, Karnataka. | 21.04.2026 | Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. | Potential Revenue Loss of Rs 5.39 lacs. |
MEDPLUS Stock Price Movement
Today, Medplus Health Services Limited shares edged higher to close at ₹890.7, marking a gain of 1.53%. The stock saw brisk activity, settling today on a total volume of 88,412 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.